Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents
Javaid Iqbal(Erasmus University Rotterdam), Stephan Windecker, Patrick W. Serruys(Ollscoil na Gaillimhe – University of Galway), Sigmund Silber(Philip Morris International (Switzerland)), Manuela Negoita(Medtronic (United States)), Gert Richardt(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Paweł Buszman(American Heart of Poland), Marie‐Angèle Morel(Ollscoil na Gaillimhe – University of Galway), Henning Kelbæk(University of Copenhagen)
Cited by 152
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
|New England Journal of Medicine|1994|4.5k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k